Amgen Inc. (AMGN) Tops Q1 EPS by 5c, Reaffirms Outlook
Tweet
Share
E-mailGet Alerts AMGN Hot Sheet
Price: $437.23 -1.55%
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.1%
Financial Fact:
Income before income taxes: 2.42B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Amgen Inc. (NASDAQ: AMGN) reported Q1 EPS of $1.34, $0.05 better than the analyst estimate of $1.29. Revenue for the quarter came in at $3.7 million versus the consensus estimate of $3.68 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen (AMGN) PT Raised to $435 at Wells Fargo
- Guidewire Software (GWRE) Tops Q4 EPS by 6c; Offers Guidance
- BRP Inc. (DOO) Reports Q2 Loss of Cd$0.18
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
